US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 97.530
  • -0.330-0.34%
Close Jan 17 16:00 ET
  • 97.530
  • 0.0000.00%
Post 20:01 ET
194.99BMarket Cap11.45P/E (TTM)

Novartis AG Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Novartis AG Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.670B--
--2024/Q4-- / 12.764B--
Oct 29, 20242024/Q312.823B / 12.666B--
Jul 18, 20242024/Q212.512B / 12.319B--
Apr 23, 20242024/Q111.829B / 11.498B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.670B--
--2024/Q4-- / 12.764B--
Oct 29, 20242024/Q312.823B / 12.666B--
Jul 18, 20242024/Q212.512B / 12.319B--
Apr 23, 20242024/Q111.829B / 11.498B--

Unlock Free Earnings Estimates

Novartis AG Earnings Reports

  • 6-K: Novartis Upgrades Mid-Term Guidance

    Nov 25, 2024 10:22 ET

  • 6-K: Financial Report Q3 2024

    Oct 29, 2024 06:23 ET

  • 6-K: Explanatory Note

    Sep 18, 2024 16:42 ET

  • 6-K: Novartis Second Quarter and Half Year 2024 Condensed Interim Financial Report – Supplementary Data

    Jul 18, 2024 06:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      33.33%

    • Hold

      66.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme CAR-T Therapy
    CAR-T Therapy
    Intraday-0.18%
    Cancer Research
    Cancer Research
    Intraday-0.95%